language_icon
EN
HI

Granules India Share price

GRANULES

689.45

2.50 (0.36%)
NSE
BSE
Last updated on 24 Apr, 2026 | 15:43 IST
Today's High

694.45

Today's Low

682.00

52 Week Low

430.70

52 Week High

696.40

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Granules India Chart

Granules India Share Key Metrics

Volume
10.12 L
Market Cap
17084.36 CR
LTQ@LTP
5@689.45
ATP
688.06
Var Margin
17.16 %
Circuit Range
549.6-824.3
Delivery %
40.01 %
Value
69.61 CR
ASM/GSM
No
Market Lot
1

Summary

24 Apr, 2026 | 15:43 को, Granules India का शेयर प्राइस आज ₹689.45 पर है, जो दिन के लिए 2.50% की 0.36 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹682.00 और ₹694.45 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹430.70 से ₹696.40 तक रही है। ट्रेडिंग गतिविधि के मामले में, Granules India ने 1011633 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹247796921 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹68806 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 5,68945 रही। यह स्टॉक ₹549.6-824.3 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹69.61 CR है। दिन के लिए डिलीवरी परसेंटेज 40.01% रही। इसके अतिरिक्त, Granules India वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Granules India Fundamentals

View More
P/E Ratio

31.2

P/B Ratio

3.84

Div. Yield

0.22

Sector P/E

65.13

Sector P/B

3.53

Sec. Div. Yield

0.57

Granules India Resistance and Support

Pivot 684.55

Resistance

First Resistance

698.8

Second Resistance

710.65

Third Resistance

724.9

Support

First Support

672.7

Second Support

658.45

Third Support

646.6

Granules India Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

38.02%

Mutual Fund

2.85%

Insurance

10.4%

Foreign Institutional Investors

15.31%

Domestic Institutional Investors

3.76%

Retail

29.67%

Others

-0.01%

Total Promoters
MAR '26
38.02%

Granules India Corporate Actions

DateAgenda
2026-04-29Audited Results & Final Dividend
2026-01-23Quarterly Results

Granules India News

Granules India Ltd-$ - 532482 - Board Meeting Intimation for Inter-Alia, To Consider And Approve The Audited Financial Results For The Fourth Quarter And Financial Year Ended On March 31, 2026 And The Recommendation Of Final Dividend For FY 2025-26, If Any.

Granules India's board is scheduled to meet on April 29, 2026. The agenda includes considering and approving the audited financial results for the fourth quarter and full fiscal year 2026, along with a recommendation for a final dividend.
Apr 16 2026 11:04:00

Granules India Ltd-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules India Limited's Chantilly, US site completed a US FDA cGMP audit with four Form 483 observations. These observations are related to procedural matters, with no data integrity issues reported. The company is committed to addressing them within stipulated timelines.
Apr 04 2026 15:04:00

Granules India Limited

Granules India's US subsidiary, Granules Pharmaceuticals, completed a routine US FDA cGMP audit at its Chantilly, Virginia site. The audit found four procedural Form 483 observations but no data integrity issues. The company commits to address these within stipulated timelines.
Apr 04 2026 15:04:00

Granules India Limited

Granules India's promoter, Dr. Krishna Prasad Chigurupati, declared that no new encumbrance has been made on the company's shares during the financial year ended March 31, 2026, other than those already disclosed. This ensures transparency regarding promoter shareholdings.
Apr 02 2026 18:04:00

Granules India Ltd-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules Life Sciences, a subsidiary of Granules India, received a Voluntary Action Indicated (VAI) classification from the US FDA for its Shamirpet manufacturing facility. The inspection, conducted between December 15 and 19, 2025, for cGMP and PAI of oral solid dosage operations, concluded with no regulatory action recommended, bolstering its finished dosage manufacturing capabilities.
Mar 31 2026 11:03:00
Read More

About Granules India AboutThe

NSE : 11872  
BSE : 532482  
ISIN : INE101D01020  

Granules India Ltd (GIL) was incorporated as a PrivateLimited Company on March 16 1991 and was later convertedinto a Public Limited Company on February 8 1993. GILcommenced its operations in April 1991 as a merchantexporter of bulk drugs like Paracetamol Guaifenesin andChloro Pheniramine Maleste. It has been exporting mainlyto the developed markets such as U.S.A. Europe Mexico andHongkong. Since 1992 GIL concentrated on export ofParacetamol powder which was procured from a GroupCompany M/s.Triton Laboratories Pvt Ltd (TLPL) a smallscale unit. In 1993-94 the international prices of bulkdrugs like Paracetamol were under pressure and GIL decidedto enter into value added areas.In April 1993 GIL also joined as a partner of M/s.TritonLaboratories (TL) a partnership firm promoted by thepromoters in 1985. After GIL became a partner. TL crestedfacilities for manufacture of DC blends of Paracetamol anddirectly entered into its export market. Later TL decidedto diversify into manufacturing of bulk drugs and startedimplementing a project for the same. In August 1994 aspart of consolidation and restructuring the Group''soperations. TL was dissolved and its assets andliabilities were taken over by GIL at book value. The assetswere independently valued by Shri S.Deshpande CharteredEngineer and approved valuer. (Rs.lakhs)Description Book Transfer Chartered value value Engineer''s valuationAssetsLand & Development *35.54 35.54 39.58Building 22.42 22.42 # 102.57Plant & Machinery 13.36 13.36) # 125.10Others 17.76 17.76)Capital work-in-progress 174.17 174.17 263.25 267.25 Investment 5.00 5.00Total (A) 268.25LiabilitiesNet current liabilities 63.27 63.27Long term liabilities 0.92 0.92Total liabilities (B) 64.19Purchase consideration (A) - (B) 204.06* The value of land purchased in 1985 for Rs.88994 wasrevalued at Rs.2826980/- on March 30 1993 at Government fixed rate of Rs.500/-per sq. yard and as valued by M/s. M. Raja Rao & Co.Chartered Engineers. Registered valuers & Insurancesurveyors. Development cost includes land leveling. # Includes Capital work-in-progressOut of the purchase consideration of Rs.204.06 lakhs theshares of the partners were as follows: - GIL - Rs.131.13 lakhs Sri Krishna Prasad - Rs. 37.47 lakhs Smt C. Uma Devi - Rs. 35.45 lakhsSri Krishna Prasad and Smt C. Uma Devi were allotted374700 and 354500 equity shares respectively of GIL ofRs. 10/- each at par in settlement of their share ofpartnership as detailed above. In addition to the above GILallotted (I) 6500 equity shares of Rs. 10/- each at par toSmt. C. Uma Devi in settlement-of rental dues for theyears 1992-93 and 1993-94 and (ii) 2600 equity shares toDr. C. Hariprasad 1500 equity shares to Dr. C. Nageswara Rao and 5000 equity shares to Smt R.Santisree all these of Rs. 10/- each and issued at partowards the long term liabilities taken over from thepartnership firm as detailed above.GIL has also purchased the assets of a sick unit from theAndhra Pradesh State Financial Corporation (APSFC) on March 30 1994. This unit was manufacturing bulk drugs.The assets comprising of land buildings and plant andmachinery were purchased for Rs.35 lakhs by availing termloan from APSFC (Rs.22.75 lakhs) and own funds (Rs.12.25lakhs). These assets are not presently used and areearmarked for future expansion needs of the companyGIL is now implementing the ongoing project taken over fromTL and is exporting DC blends of Paracetamol ofinternational pharmacopial standards from September 11994. Trial production of Folic Acid commenced in November1994 and commercial production in August 1995. The list of GIL''s clients include M/s.Roussel CorporationHelm New York Chemical Corporation and Granutec all ofU.S.A Welding GMBH & Co of Germany and Flavine Espana S.A.of Spain.

Read More

Granules India Management

NamePosition
Krishna Prasad ChigurupatiChairman & Managing Director
Uma Devi ChigurupatiWhole Time Director
View More

Granules India FAQs

Granules India शेयर का खरीद मूल्य 689.45 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Granules India शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Granules India शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 31.2 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Granules India शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.84 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Granules India शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.53 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Granules India का मार्केट कैप 17084.36 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Granules India शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 696.40 और 430.70 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost